SSR504734
SSR504734 is an orally active, selective and reversible inhibitor of human, rat, and mouse GlyT1 (IC50=18, 15, and 38 nM, respectively) . SSR504734 shows anti-schizophrenia, anti-anxiety and anti-depression activities[1].
Product Specifications
CAS Number
615571-23-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
GlyT
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ssr504734.html
Purity
99.82
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C(C(C(F)(F)F)=CC=C1)Cl)N[C@H]([C@]2([H])CCCCN2)C3=CC=CC=C3.Cl
Molecular Formula
C20H21Cl2F3N2O
Molecular Weight
433.29
Precautions
H302, H315, H319, H335
References & Citations
[1]Ronan Depoortère, et al. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology. 2005 Nov;30 (11) :1963-85.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GlyT1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B391025-10MG 10 mg
3-(4-(N-Biotinoyl-6-aminocaproyloxy)phenyl)propionic Acid, N-Hydroxysuccinimide Ester
Sign In for Pricing
View Details 
BNC681829-500 1x 500 µL
CD20 / MS4A1 (B-Cell Marker) (rIGEL/773), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
